FOR MORE INFORMATION: Date: April 28, 1997 Endocrine Society 4350 East West Highway Suite 500 Bethesda, Md. 20814-4410 Tel: (301) 941-0200 Fax: (301) 941-0259 E-mail: endostaff@endo-society.org http://www.endo-society.org 8,000 members Executive director: Scott Hunt President: P. Michael Conn Relevant journal: Journal of Clinical Endocrinology and Metabolism National Institute on Aging fact sheet (includes section on DHEA): http://www.nih.gov/nia/ The following references p
Endocrine Society
4350 East West Highway
Suite 500
Bethesda, Md. 20814-4410
Tel: (301) 941-0200
Fax: (301) 941-0259
E-mail: endostaff@endo-society.org
http://www.endo-society.org
The following references provide reviews of basic and clinical research on DHEA:
In mammals, intracellular clocks begin to tick within days of fertilization.
View this Issue
Learn how mastering the ins and outs of PCR can accelerate workflows and improve data.
Polypharmacology allows scientists to explore novel therapeutic purposes for existing drugs and opens new doors to treat multifactorial diseases.
Molecular detection technologies help scientists rapidly and reliably find and address ever-evolving pathogens with optimal accuracy and sensitivity.
Discover the key features to consider when selecting a new refrigerator or freezer
On February 18, 2025, Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 capsid inhibitor for pre-exposure prophylaxis (PrEP).
Slow temperature recovery can threaten the integrity of your work. That’s Stirling Ultracold designed the VAULT100™ to operate at setpoints down to -100°C, so your samples may never be exposed to temperatures above -70°C during a typical door opening.
The next generation imager from the ChemiDoc Imaging System line. Effortlessly capture gel and western blot images from your benchtop without compromising on sensitivity and precision.
• Ongoing strategic partnership advances joint pipeline in neurodegeneration research
• Evotec receives a $20 million payment to further progress research
